This simultaneous suppression of fibrotic marker expression and cellular motility upon MMP14 blockade strongly indicates that selective targeting of this metalloproteinase represents a promising therapeutic strategy to mitigate orbital tissue fibrosis in GO. Here, MMP14 is linked to geroderma osteodysplastica.